Fig. 6From: Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysisForest plot of the incident of upper respiratory tract infection in TSC patients with or without mTOR inhibitorsBack to article page